Cigna Group announced Monday it is not pursuing a merger with Humana. The announcement squashes speculation fueled by Donald ...
"The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are ...
Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.
Shares of The Cigna Group CI jumped 7.3% yesterday after it clarified in a press release that it's not pursuing a merger with ...
Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not ...
Last December, the two companies failed to agree on a price as Cigna pursued the purchase of the Louisville-based company.
The potential merger of Cigna and Humana could have a better chance of success than under the Democrats, though we still see increasing claims concentration in the PBM industry as a concern. Also, the ...
Shares of Humana had been among the major health-care gainers in the wake of Donald Trump's victory as traders anticipated a Trump administration approving merger plans that Federal Trade Commission ...
Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.
Since the start of the year, Humana stock is underperforming with a 39.4% deficit ... and have nearly filled their Oct. 18 ...
The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana ...
Humana shares are tumbling in premarket trading Monday after The Cigna Group said it is not pursuing a merger with its smaller health insurance rival.